How To Diagnose And Treat Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immunotherapy

If corticosteroids are not an option for a chronic inflammatory demyelinating polyneuropathy patient, immunotherapy may be added to help mediate their symptoms. Immunotherapy is a treatment typically used to slow down the actions of an individual's immune system. This mechanism is difficult to achieve because it involves leaving some parts of the patient's immune system active and functioning, while selectively deactivating the parts of the immune system causing the CIDP symptoms. Other methods in immunotherapy used to treat autoimmune disorders like CIDP are not specific to the particular parts of the immune system that cause the specific disorder. This non-specificity results in adverse side effects some patients may not be able to handle. Immunotherapy is the manipulation of the individual's immune system responses to treat the imbalance without causing significant adverse side effects.
Uncover additional treatments for chronic demyelinating polyneuropathy now.